Investigational drug · Phase 2
ARD001
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Hemophilia A, Healthy Adult Participants.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "ARD001"
First trial start
2026
Aug 19, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ARD001", any sponsor or status.
Conditions studied
As listed on its trial records.
- Hemophilia A
- Healthy Adult Participants
Approved drugs for the same conditions: Hemophilia · Hematology and blood cancers
Largest trials
Live from ClinicalTrials.gov: studies naming "ARD001" as an intervention, largest first.
Arditus Pte LtdIndustry
NCT07787091 · 20 participants (planned) · Start Aug 19, 2026 · Primary completion Mar 2027
Drug: ARD001 · For: Hemophilia A; Healthy Adult Participants
Sites: Singapore, Singapore
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Hemophilia A
- SR604Phase 34 trials
Shanghai RAAS Blood Products Co., Ltd. · Factor VII Deficiency, Hemophilia A, Hemophilia B
- BIVV001efanesoctocog, AltuvoctPhase 33 trials
Swedish Orphan Biovitrum · Haemophilia A (Moderate or Severe), Hemophilia A, Hemophilia A, Severe
- GS1191-0445Phase 32 trials
Gritgen Therapeutics Co., Ltd. · Severe Hemophilia A, Hemophilia A
- NXT007Zemocimig, RO7589655Phase 32 trials
Roche (Genentech) · Hemophilia A
- Valoctocogene roxaparvovecBMN 270, GENEr8Phase 32 trials
BioMarin · Hemophilia A, Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII
- ASC618Phase 21 trial
ASC Therapeutics · Hemophilia A
- BAY2599023DTX201Phase 21 trial
Bayer · Hemophilia A
- SPK-8011QQRO7878488Phase 21 trial
Roche (Genentech) · Hemophilia A
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.